Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 1
2006 1
2007 4
2008 2
2010 1
2011 2
2012 1
2013 3
2014 1
2015 2
2016 2
2017 8
2018 6
2019 3
2020 4
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Rayego-Mateos S, et al. Among authors: mas s. Int J Mol Sci. 2020 May 27;21(11):3798. doi: 10.3390/ijms21113798. Int J Mol Sci. 2020. PMID: 32471207 Free PMC article. Review.
Animal models of cardiovascular diseases.
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A, Egido J. Zaragoza C, et al. Among authors: mas s. J Biomed Biotechnol. 2011;2011:497841. doi: 10.1155/2011/497841. Epub 2011 Feb 16. J Biomed Biotechnol. 2011. PMID: 21403831 Free PMC article. Review.
Proteomics in atherosclerosis.
Martinez-Pinna R, Martin-Ventura JL, Mas S, Blanco-Colio LM, Tuñon J, Egido J. Martinez-Pinna R, et al. Among authors: mas s. Curr Atheroscler Rep. 2008 Jun;10(3):209-15. doi: 10.1007/s11883-008-0033-z. Curr Atheroscler Rep. 2008. PMID: 18489848 Review.
Atrasentan for the treatment of diabetic nephropathy.
Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C. Egido J, et al. Among authors: mas s. Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Expert Opin Investig Drugs. 2017. PMID: 28468519 Review.
Protective Role of Nrf2 in Renal Disease.
Guerrero-Hue M, Rayego-Mateos S, Vázquez-Carballo C, Palomino-Antolín A, García-Caballero C, Opazo-Rios L, Morgado-Pascual JL, Herencia C, Mas S, Ortiz A, Rubio-Navarro A, Egea J, Villalba JM, Egido J, Moreno JA. Guerrero-Hue M, et al. Among authors: mas s. Antioxidants (Basel). 2020 Dec 31;10(1):39. doi: 10.3390/antiox10010039. Antioxidants (Basel). 2020. PMID: 33396350 Free PMC article. Review.
Vascular proteomics.
Vivanco F, Mas S, Darde VM, De la Cuesta F, Alvarez-Llamas G, Barderas MG. Vivanco F, et al. Among authors: mas s. Proteomics Clin Appl. 2007 Sep;1(9):1102-22. doi: 10.1002/prca.200700190. Proteomics Clin Appl. 2007. PMID: 21136761
Targeting inflammation in diabetic nephropathy: a tale of hope.
Moreno JA, Gomez-Guerrero C, Mas S, Sanz AB, Lorenzo O, Ruiz-Ortega M, Opazo L, Mezzano S, Egido J. Moreno JA, et al. Among authors: mas s. Expert Opin Investig Drugs. 2018 Nov;27(11):917-930. doi: 10.1080/13543784.2018.1538352. Epub 2018 Oct 23. Expert Opin Investig Drugs. 2018. PMID: 30334635 Review.
Incidence of Hypersensitivity Reactions During Hemodialysis.
Esteras R, Martín-Navarro J, Ledesma G, Fernández-Prado R, Carreño G, Cintra M, Cidraque I, Sanz I, Tarragón B, Alexandru S, Milla M, Astudillo E, Sánchez E, Mas S, Tejeiro RD, Ortiz A, Sánchez R, González-Parra E. Esteras R, et al. Among authors: mas s. Kidney Blood Press Res. 2018;43(5):1472-1478. doi: 10.1159/000493662. Epub 2018 Sep 20. Kidney Blood Press Res. 2018. PMID: 30235456 Free article.
42 results